Navigation Links
CLAAD Selects Egalet As Top Five Technologies To Reduce Prescription Drug Abuse Honoree

WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) today recognized Egalet Ltd., a specialty pharmaceutical company focused on developing safe, effective, and tamper-resistant medications, as a Top Five Technologies To Reduce Prescription Drug Abuse honoree.

Egalet is developing a pipeline of tamper-resistant opioids that are nearing pivotal testing.

Roland Gerritsen van der Hoop, Chief Medical Officer of Egalet, received the award on behalf of the company during the National Prescription Drug Abuse Prevention Policy Consensus Meeting in Washington, DC.

"We are honored to be recognized by CLAAD for our efforts to bring to market abuse-resistant opioids," said Bob Radie, CEO and president of Egalet. "We believe our erosion-based delivery technology will help improve the safe delivery of opioids."

The Top 5 Technologies competition aims to increase public awareness of the U.S. prescription drug abuse epidemic, and to support private-sector efforts to address the problem.

Michael Barnes, spokesman for CLAAD, stated, "We are pleased to honor Egalet for its work to develop pharmaceutical products that are less susceptible to tampering and abuse."

San Diego-based Millennium Laboratories co-sponsored the Top 5 Technologies contest. Millennium provides medication monitoring, drug detection and pharmacogenetic testing services.

"We are proud to recognize Egalet for joining Millennium and CLAAD in our efforts to advance patient care and reduce prescription drug abuse," said Howard Appel, President of Millennium Laboratories. 

About the Center for Lawful Access and Abuse Deterrence
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) is a national coalition of health care providers, law enforcement, community organizations, and businesses working together to reduce prescription drug abuse while optimizing patient care. Visit, and follow @claad_coalition

About Millennium Laboratories
Millennium Laboratories is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. The company provides healthcare professionals with medication monitoring, drug detection and pharmacogenetic testing services to personalize treatment plans to improve clinical outcomes and patient safety. 

About Egalet Ltd.
Egalet Ltd. is a specialty pharmaceutical company using patented technology to produce a pipeline of tamper-resistant opioids that are nearing pivotal testing.  Egalet has pioneered one of the world's first erosion-based delivery technologies to enable the controlled release of medications through gradual erosion of a tablet.  

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CLAAD Warns of Increase in Prescription Drug Overdoses
2. CLAAD Names Eagle Advancement Institute as Honoree of Top 5 Technologies To Reduce Prescription Drug Abuse
3. CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse
4. CLAAD Recognizes SMART/Script as Top 5 Technology To Reduce Rx Abuse
5. CLAAD Recognizes The Locking Cap as Top 5 Technology To Reduce Rx Abuse
6. Angeion Selects Hendrik Struik for Board of Directors
7. PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor
8. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
9. ZyDoc Selects Health Fidelitys REVEAL™ Natural Language Processing (NLP) Platform to Accelerate Time to Value for its MediSapien Web Services
10. Pokagon Band of Potawatomi selects iSALUS Healthcares OfficeEMR™ Solution
11. ICON Medical Imaging Selects AG Mednet to Give Clinical Trial Sponsors Zero-Delay Efficiency and Faster Decision-Making Results
Post Your Comments:
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... 23, 2016 , , , ... 7, 2016 , , , , LOCATION: , , , ... , , , EXPERT PANELISTS:  , , , Frost & Sullivan,s ... Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program ... global pharmaceutical industry is witnessing an exceptional era. Several new demand ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... is actively feeding the Frederick area economy by obtaining investment capital for emerging ... the past 2½ years that have already resulted in more than a million ...
Breaking Medicine News(10 mins):